Canadians: 2 Cheap Healthcare Stocks to Own in Your TFSA Forever

The healthcare sector is booming, and stocks like Savaria Corporation (TSX:SIS) can be had for cheap as global stocks are being routed right now.

| More on:
Pills pharma

Image source: Getty Images

Health care is a sector that has rivaled technology with its propensity to excite the investing world. According to a recent report from ResearchAndMarkets, the global healthcare market reached a value of $8.45 trillion in 2018. It projects that this market will reach $11.9 trillion by 2022. This would represent a CAGR of 8.9% over the forecast period.

In previous articles, I’d discussed why the Tax-Free Savings Account is such an effective growth vehicle. Healthcare stocks make a great target for investors who are hungry for potentially massive long-term growth.

The coronavirus outbreak has stirred global panic, and markets have been pummeled in the final week of February. Healthcare stocks have not been spared, but the fears surrounding this outbreak also illustrate just how crucial the development of this sector is going forward. Today, I want to look at two healthcare-linked stocks that would make a terrific hold in a TFSA to start this decade.


Canada and most of the developed world are facing rapidly expanding senior citizen populations. Aging demographics will have an enormous impact on the healthcare sector. Savaria (TSX:SIS) is a stock I’ve been bullish on for some time now. This company designs, engineers, and manufactures products for personal mobility in Canada, the United States, and countries around the world.

Shares of Savaria have plunged 10% over the past week at the time of this writing. The stock has struggled over the past year — falling 5% as of close on February 26 — but it has been a high performer over the past decade. A Reports and Data forecast released in 2019 projected that the personal mobility devices market would reach $12.4 billion by 2026, which would represent a CAGR of 6.7% over the forecast period.

Savaria stock last possessed a P/E ratio of 26 and a P/B value of 2.3, which sits below the industry average. The company is moving forward with an excellent balance sheet. Shares last had an RSI of 26, which puts Savaria in technically oversold territory. Better yet, Savaria offers a monthly dividend of $0.0383 per share. This represents a 3.7% yield.

CRH Medical

CRH Medical (TSX:CRH) is a Vancouver-based company that, through its subsidiaries, provides anesthesiology services to gastroenterologists in the United States. Its shares had plunged 10.7% over the past week as of close on February 26. However, the stock was still up 16% year over year.

Investors can expect to see its fourth-quarter and full-year results for 2019 in March. In the third quarter, total revenue rose 5.9% year over year to $30.4 million, and adjusted operating EBITDA increased 42.9% to $13.1 million. In the year-to-date period, total adjusted operating EBITDA climbed to $39.4 million compared to $38.8 million in the first nine months of 2018.

This company boasts solid growth potential as we look ahead. A report from Grand View Research recently projected that the gastrointestinal therapeutics market would register a CAGR of 6.6% from 2018 through 2025. CRH Medical stock is in favourable value territory compared to its industry peers, as it currently possesses a price-to-book value of 3.4. Investors should keep an eye on its stock, as it is trending towards technically oversold territory at the time of this writing.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool recommends CRH Medical and Savaria.

More on Dividend Stocks

Various Canadian dollars in gray pants pocket
Dividend Stocks

Got $5,000? Double it With This Passive-Income Stock

This passive-income stock has strong growth ahead as well as a solid dividend. This could lead to you doubling a…

Read more »

Dividend Stocks

Here’s the Next Dividend Stock I’m Going to Buy

As the fear of recession increases, panic increases. At times like these, a dividend stock can mitigate your portfolio's downside.

Read more »

worry concern
Dividend Stocks

Housing Market in May 2022: Buyers and Sellers Are in a Bind

Many homebuyers are re-evaluating their options due to rising inflation and mortgage rates, but sellers hope they would change their…

Read more »

Money growing in soil , Business success concept.
Dividend Stocks

3 Low-Yield Stocks to Buy for Decent Growth Potential

A low yield doesn't always mean that the company is a miser with its payouts. Sometimes, it's the result of…

Read more »

edit Safety First illustration
Dividend Stocks

3 of the Safest High-Yield Dividend Stocks in Canada

Not all high-yield stocks are inherently dangerous, but it’s still a good idea to play it safe and choose companies…

Read more »

A stock price graph showing growth over time
Dividend Stocks

RRSP Investors: 2 Oversold TSX Stocks to Buy for Dividend Growth

The market pullback is giving RRSP investors a chance to buy some top TSX dividend stocks at cheap prices.

Read more »

stock research, analyze data
Dividend Stocks

Buy the Dip: 2 Top TSX Dividend Stocks on Sale

These top TSX dividend stocks look cheap to buy today for a portfolio focused on passive income.

Read more »

grow money, wealth build
Dividend Stocks

2 Top TSX Growth Stocks That Also Pay Investors Tasty Dividends

Growth stocks on the TSX such as goeasy and Brookfield Renewable also provide investors with tasty dividend yields.

Read more »